The DOI matches its Crossref record; 226 of the 226 references it cites were found in a registry or an index.
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Open accessAbstract
Poly (lactic-co-glycolic acid) (PLGA) is one of the most effective biodegradable polymeric nanoparticles (NPs). It has been approved by the US FDA to use in drug delivery systems due to controlled and sustained- release properties, low toxicity, and biocompatibility with tissue and cells. In the present review, the structure and properties of PLGA copolymers synthesized by ring-opening polymerization of DL-lactide and glicolide were characterized using 1H nuclear magnetic resonance spectroscopy, gel permeation chromatography, Fourier transform infrared spectroscopy and differential scanning calorimetry. Methods of preparation and characterization, various surface modifications, encapsulation of diverse anticancer drugs, active or passive tumor targeting and different release mechanisms of PLGA nanoparticles are discussed. Increasing experience in the application of PLGA nanoparticles has provided a promising future for use of these nanoparticles in cancer treatment, with high efficacy and few side effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Anand, P., Nair, H. B., Sung, B., Kunnumakkara, A. B., Yadav, V. R., Tekmal, R. R., & Aggarwal, B. B. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.09.003 · Cited by 574
RetractedDavaran, S., Asgari, D., Davaran, S., Akbarzadeh, A., Zarghami, Mikaeili, H., & Mohamad, R. (2012) · International Journal of Nanomedicine · doi:10.2147/ijn.s24326 · Cited by 144
Self-citationRetractedAkbarzadeh, A., Samiei, M., Joo, S. W., Anzaby, M., Hanifehpour, Y., Nasrabadi, H. T., & Davaran, S. (2012) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-10-46 · Cited by 122
Self-citationRetractedDavaran, S., Asgari, D., Goganian, A. M., Khiabani, H. K., Davaran, S., Akbarzadeh, A., Mikaeili, H., Samiei, M., Zarghami, N., & Mohamad, R. (2012) · Nanotechnology Science and Applications · doi:10.2147/nsa.s24328 · Cited by 75
Self-citationRetractedJemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233 · cited 2×
“decreases damage to healthy cells and diminishes the recovery period (Peer et al., 2007; Davis, 2008; Lammers et al., 2008; Dinarvand et al., 2011).”
BackgroundPLGA-based nanoparticles: An overview of biomedical applications
Danhier, F., Ansorena, E., Silva, J. M., Coco, R., Le Breton, A., & Préat, V. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.043 · Cited by 3,806
Integrins in cancer: biological implications and therapeutic opportunities
Desgrosellier, J. S., & Cheresh, D. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2748 · Cited by 3,736
Biodegradable polymeric nanoparticles based drug delivery systems
Kumari, A., Yadav, S. K., & Yadav, S. C. (2010) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/j.colsurfb.2009.09.001 · Cited by 3,724
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Liposome: classification, preparation, and applications
Akbarzadeh, A., Rezaei-Sadabady, R., Davaran, S., Joo, S. W., Zarghami, N., Hanifehpour, Y., Samiei, M., Kouhi, M., & Nejati-Koshki, K. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-102 · Cited by 3,632
Self-citationTargeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609 · cited 1×
“After a long period of chemotherapy, numerous patients suffer from MDR, which can decrease therapy efficiency and cause to treatment failure (Szakács et al., 2006; Li et al., 2012).”
BackgroundBiodegradable polymeric nanoparticles as drug delivery devices
Soppimath, K. S., Aminabhavi, T. M., Kulkarni, A. R., & Rudzinski, W. E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00339-4 · Cited by 3,549
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Therapeutic Nanoparticles for Drug Delivery in Cancer
Cho, K., Wang, X., Nie, S., Chen, Z. (., & Shin, D. M. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1441 · Cited by 2,920
Danhier, F., Feron, O., & Préat, V. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.08.027 · Cited by 2,800
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Pal, M., Pal, U., Jiménez, J. M. G. Y., & Pérez-Rodríguez, F. (2012) · Nanoscale Research Letters · doi:10.1186/1556-276x-7-1 · Cited by 2,620
Nanocapsule formation by interfacial polymer deposition following solvent displacement
Fessi, H., Puisieux, F., Devissaguet, J. P., Ammoury, N., & Benita, S. (1989) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(89)90281-0 · Cited by 2,288
Jain, R. A. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00115-0 · Cited by 2,214
(2016) · CRC Press eBooks · doi:10.1201/b12801 · Cited by 2,031
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029 · cited 1×
“are taken up by liver to a minor extent (Araujo et al., 1999; Moghimi et al., 2005; Mozafari et al., 2009).”
BackgroundTransport properties of two finite armchair graphene nanoribbons
Rosales, L., & González, J. W. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-1 · Cited by 1,956
VEGF as a Key Mediator of Angiogenesis in Cancer
Carmeliet, P. (2005) · Oncology · doi:10.1159/000088478 · Cited by 1,768
Active targeting schemes for nanoparticle systems in cancer therapeutics
Byrne, J. D., Betancourt, T., & Brannon-Peppas, L. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.005 · Cited by 1,731
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S., Blunk, T., & Müller, R. H. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00156-3 · Cited by 1,723
Ligand-targeted therapeutics in anticancer therapy
Allen, T. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc903 · Cited by 1,647
(1989) · PubMed · Cited by 1,639
Nanocarriers’ entry into the cell: relevance to drug delivery
Hillaireau, H., & Couvreur, P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0053-z · Cited by 1,552
Expression of a multidrug-resistance gene in human tumors and tissues.
Fojo, A. T., Ueda, K., Slamon, D. J., Poplack, D. G., Gottesman, M. M., & Pastan, I. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.1.265 · Cited by 1,544
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles
Pinto Reis, C., Neufeld, R. J., Ribeiro, & Veiga, F. (2006) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2005.12.003 · Cited by 1,354
Biodegradable nanoparticles for drug delivery and targeting
Hans, M. L., & Lowman, A. M. (2002) · Current Opinion in Solid State and Materials Science · doi:10.1016/s1359-0286(02)00117-1 · Cited by 1,324
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems—A review
Fredenberg, S., Wahlgren, M., Reslow, M., & Axelsson, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.049 · Cited by 1,286
Formulation of functionalized PLGA-PEG Nanoparticles for in vivo targeted drug delivery
Cheng, J., Teply, B. A., Sherifi, I., Sung, J., Luther, G., Gu, F. X., Levy-Nissenbaum, E., Radovic-Moreno, A. F., Langer, R., & Farokhzad, O. C. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.09.047 · Cited by 1,273
Magnetic nanoparticles: preparation, physical properties, and applications in biomedicine
Akbarzadeh, A., Samiei, M., & Davaran, S. (2012) · Nanoscale Research Letters · doi:10.1186/1556-276x-7-144 · Cited by 1,241
Self-citationMohanraj, V. J., & Chen, Y. (2007) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v5i1.14634 · Cited by 1,217
Nanotech approaches to drug delivery and imaging
Sahoo, S. K., & Labhasetwar, V. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02903-9 · Cited by 1,203
Polymers for the sustained release of proteins and other macromolecules
LANGER, R., & FOLKMAN, J. (1976) · Nature · doi:10.1038/263797a0 · Cited by 1,182
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
Maeda, H., Bharate, G. Y., & Daruwalla, J. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.11.010 · Cited by 1,168
Kirpotin, D. B., Drummond, D. C., Shao, Y., Shalaby, M. R., Hong, K., Nielsen, U. B., Marks, J. D., Benz, C. C., & Park, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4199 · Cited by 1,125
PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect
Acharya, S., & Sahoo, S. K. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.10.008 · Cited by 1,112
Structure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., & Maitra, A. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-3 · Cited by 1,090
Nanoparticles for drug delivery: The need for precision in reporting particle size parameters
Gaumet, M., Vargas, A., Gurny, R., & Delie, F. (2008) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2007.08.001 · Cited by 1,081
P-glycoprotein: from genomics to mechanism
Ambudkar, S. V., Kimchi-Sarfaty, C., Sauna, Z. E., & Gottesman, M. M. (2003) · Oncogene · doi:10.1038/sj.onc.1206948 · Cited by 1,074
Panyam, J., Zhou, W., Prabha, S., Sahoo, S. K., & Labhasetwar, V. (2002) · The FASEB Journal · doi:10.1096/fj.02-0088com · Cited by 1,044
Mundargi, R. C., Babu, V. R., Rangaswamy, V., Patel, P., & Aminabhavi, T. M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.09.013 · Cited by 1,025
Govender, T. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00116-3 · Cited by 1,008
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 966
Shaikh, J., Ankola, D. D., Beniwal, V., Singh, D., & Kumar, M. N. V. R. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.019 · Cited by 956
Nanotechnology applications in cancer
Nie, S., Xing, Y., Kim, G. J., & Simons, J. W. (2007) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.9.060906.152025 · Cited by 952
Methods for the Preparation and Manufacture of Polymeric Nanoparticles
Vauthier, C., & Bouchemal, K. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9800-3 · Cited by 929
Maeda, H., Sawa, T., & Konno, T. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00309-1 · Cited by 925
The Epidermal Growth Factor Receptor Pathway: A Model for Targeted Therapy
Scaltriti, M., & Baselga, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1554 · Cited by 913
Current advances in research and clinical applications of PLGA-based nanotechnology
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.15 · Cited by 903
Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system
Storm, G., Belliot, S. O., Daemen, T., & Lasic, D. D. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00039-a · Cited by 877
Foged, C., Brodin, B., Frokjaer, S., & Sundblad, A. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.03.035 · Cited by 871
Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles
Wischke, C., & Schwendeman, S. P. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.042 · Cited by 790
Synthesis and characterization of PLGA nanoparticles
Astete, C. E., & Sabliov, C. M. (2006) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856206775997322 · Cited by 776
Fonseca, C., Simões, S., & Gaspar, R. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00212-2 · Cited by 755
PLGA Nanoparticles in Drug Delivery: The State of the Art;
Bala, I., Hariharan, S., & Kumar, M. R. (2004) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v21.i5.20 · Cited by 739
Mu, L., & Feng, S. S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00320-6 · Cited by 725
Curcumin: Getting Back to the Roots
SHISHODIA, S., SETHI, G., & AGGARWAL, B. B. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1352.010 · Cited by 715
Long circulating microparticulate drug carriers
Stolnik, S., Illum, L., & Davis, S. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00025-3 · Cited by 700
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Torchilin, V. P. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00166-4 · Cited by 680
Degradation of poly(lactic-co-glycolic acid) microspheres: Effect of copolymer composition
Park, T. G. (1995) · Biomaterials · doi:10.1016/0142-9612(95)93575-x · Cited by 642
Adams, G. P., Schier, R., McCall, A. M., Simmons, H. H., Horak, E. M., Alpaugh, R. K., Marks, J. D., & Weiner, L. M. (2001) · PubMed · Cited by 629
Liu, Y., Miyoshi, H., & Nakamura, M. (2007) · International Journal of Cancer · doi:10.1002/ijc.22709 · Cited by 620
Design of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620
Paclitaxel-loaded PEGylated PLGA-based nanoparticles: In vitro and in vivo evaluation
Danhier, F., Lecouturier, N., Vroman, B., Jérôme, C., Marchand-Brynaert, J., Feron, O., & Préat, V. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.086 · Cited by 616
Quintanar-Guerrero, D., Allémann, E., Fessi, H., & Doelker, E. (1998) · Drug Development and Industrial Pharmacy · doi:10.3109/03639049809108571 · Cited by 589
Jung, T. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00084-9 · Cited by 588
Folate-targeted therapeutic and imaging agents for cancer
Low, P. S., & Kularatne, S. A. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.03.022 · Cited by 585
The rapamycin-sensitive signal transduction pathway as a target for cancer therapy
Hidalgo, M., & Rowinsky, E. K. (2000) · Oncogene · doi:10.1038/sj.onc.1204091 · Cited by 582
Yallapu, M. M., Gupta, B. K., Jaggi, M., & Chauhan, S. C. (2010) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2010.05.022 · Cited by 579
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.018 · Cited by 577
Emerging use of nanoparticles in diagnosis and treatment of breast cancer
Yezhelyev, M. V., Gao, X., Xing, Y., Al-Hajj, A., Nie, S., & O'Regan, R. M. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70793-8 · Cited by 577
Delivery of Novel Therapeutic Agents in Tumors: Physiological Barriers and Strategies
Jain, R. K. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/81.8.570 · Cited by 557
Mittal, G., Sahana, D. K., Bhardwaj, V., & Ravi Kumar, M. N. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.01.016 · Cited by 551
Tumour-targeted nanomedicines: principles and practice
Lammers, T., Hennink, W. E., & Storm, G. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604483 · Cited by 542
PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats
Li, Y.-P., Pei, Y.-Y., Zhang, X.-Y., Gu, Z.-H., Zhou, Z.-H., Yuan, W.-F., Zhou, J.-J., Zhu, J.-H., & Gao, X.-J. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00218-8 · Cited by 540 · cited 2×
“, 2005), Fourier transform infrared spectroscopy (Li et al., 2001; Choi and Kim, 2007; Yang et al., 2007) and Nuclear magnetic resonance spectroscopy (Li et al.”
BackgroundMethodZambaux, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00106-5 · Cited by 537
Biodegradable nanoparticles for cytosolic delivery of therapeutics
VASIR, J., & LABHASETWAR, V (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.003 · Cited by 526
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Daniels, T. R., Delgado, T., Helguera, G., & Penichet, M. L. (2006) · Clinical Immunology · doi:10.1016/j.clim.2006.06.006 · Cited by 518
Charles F. Kettring prize. Fundamental studies with cisplatin
Rosenberg, B. (1985) · Cancer · doi:10.1002/1097-0142(19850515)55:10<2303::aid-cncr2820551002>3.0.co;2-l · Cited by 517
Avgoustakis, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00530-2 · Cited by 503
Preparation and characterization of cationic PLGA nanospheres as DNA carriers
Ravi Kumar, M. N. V., Bakowsky, U., & Lehr, C. M. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2003.08.069 · Cited by 492
Which polymers can make nanoparticulate drug carriers long-circulating?
Torchilin, V. P., & Trubetskoy, V. S. (1995) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(95)00022-y · Cited by 480
Chan, S., Scheulen, M. E., Johnston, S., Mross, K., Cardoso, F., Dittrich, C., Eiermann, W., Hess, D., Morant, R., Semiglazov, V., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.66.130 · Cited by 468
Drug-loaded nanoparticles : preparation methods and drug targeting issues
Allémann, É., Gurny, R., & Doelker, É. (1993) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 454
Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents
Dinarvand, R., Sepehri, N., Manouchehri, Rouhani, & Atyabi, F. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s18905 · Cited by 453
Dunne, M., Corrigan, O. I., & Ramtoola, Z. (2000) · Biomaterials · doi:10.1016/s0142-9612(00)00040-5 · Cited by 444
Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee, A., & Vishwanatha, J. K. (2009) · PubMed · Cited by 444
EGFR Signaling and Drug Discovery
Lurje, G., & Lenz, H.-J. (2009) · Oncology · doi:10.1159/000279388 · Cited by 442
New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy
Park, K., Lee, S., Kang, E., Kim, K., Choi, K., & Kwon, I. C. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200801655 · Cited by 432
Polymeric nanoparticles for cancer therapy
Parveen, S., & Sahoo, S. K. (2008) · Journal of Drug Targeting · doi:10.1080/10611860701794353 · Cited by 427
Biodegradation of PLA/GA polymers: increasing complexity
Vert, M., Mauduit, J., & Li, S. (1994) · Biomaterials · doi:10.1016/0142-9612(94)90271-2 · Cited by 425
Zhang, Z., & Feng, S.-S. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.03.006 · Cited by 414
Choi, A. O., Cho, S. J., Desbarats, J., Lovrić, J., & Maysinger, D. (2007) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-5-1 · Cited by 410
Biodegradable Nanoparticles for Targeted Drug Delivery in Treatment of Inflammatory Bowel Disease
Lamprecht, A., Ubrich, N., Yamamoto, H., Schäfer, U., Takeuchi, H., Maincent, P., Kawashima, Y., & Lehr, C.-M. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29290-9 · Cited by 403
Poly(d,l-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs
Dong, Y., & Feng, S.-S. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.021 · Cited by 395
Poloxamers and poloxamines in nanoparticle engineering and experimental medicine
Moghimi, S. M., & Hunter, A. C. (2000) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)01485-2 · Cited by 392
In vitro and in vivo anti-tumor activities of nanoparticles based on doxorubicin–PLGA conjugates
Yoo, H. S., Lee, K. H., Oh, J. E., & Park, T. G. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00280-7 · Cited by 374
Tobı́o, M., Sánchez, A., Vila, A., Soriano, I., Evora, C., Vila-Jato, J. L., & Alonso, M. J. (2000) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00157-5 · Cited by 368
Nanovehicular Intracellular Delivery Systems
Prokop, A., & Davidson, J. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21270 · Cited by 363
Degradation of poly (D,L-lactic acid) microspheres: Effect of molecular weight
Park, T. G. (1994) · Journal of Controlled Release · doi:10.1016/0168-3659(94)90263-1 · Cited by 359
Multifunctional Nanoparticles for Combined Doxorubicin and Photothermal Treatments
Park, H., Yang, J., Lee, J., Haam, S., Choi, I.-H., & Yoo, K.-H. (2009) · ACS Nano · doi:10.1021/nn900215k · Cited by 359
Controlled drug delivery with nanoparticles : current possibilities and future trends
Couvreur, P., Dubernet, C., & Puisieux, F. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 356
Multi-functional polymeric nanoparticles for tumour-targeted drug delivery
van Vlerken, L. E., & Amiji, M. M. (2006) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.3.2.205 · Cited by 352
Role of aminopeptidase N (CD13) in tumor‐cell invasion and extracellular matrix degradation
Saiki, I., Yoneda, J., Azuma, I., Fujii, H., Abe, F., Nakajima, M., & Tsuruo, T. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540122 · Cited by 341
Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy
Acharya, S., Dilnawaz, F., & Sahoo, S. K. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.008 · Cited by 333
PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination
Garinot, M., Fiévez, V., Pourcelle, V., Stoffelbach, F., des Rieux, A., Plapied, L., Theate, I., Freichels, H., Jérôme, C., Marchand-Brynaert, J., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.021 · Cited by 331
Mosqueira, V. C. F., Legrand, P., Gulik, A., Bourdon, O., Gref, R., Labarre, D., & Barratt, G. (2001) · Biomaterials · doi:10.1016/s0142-9612(01)00043-6 · Cited by 325
Effect of Different Antilipidemic Agents and Diets on Mortality: A Systematic Review
Studer, M., Briel, M., Leimenstoll, B., Glass, T. R., & Bucher, H. C. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.7.725 · Cited by 318
Bilati, U., Allémann, E., & Doelker, E. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.10.006 · Cited by 313
Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel
Feng, S.-S., Mu, L., Win, K., & Huang, G. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043455909 · Cited by 311
Panyam, J., Sahoo, S. K., Prabha, S., Bargar, T., & Labhasetwar, V. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00295-3 · Cited by 308
Jain, R. K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00306-6 · Cited by 298
Gelperina, S., Maksimenko, O., Khalansky, A., Vanchugova, L., Shipulo, E., Abbasova, K., Berdiev, R., Wohlfart, S., Chepurnova, N., & Kreuter, J. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2009.09.003 · Cited by 293
Determinants of Rapamycin Sensitivity in Breast Cancer Cells
Noh, W.-C., Mondesire, W. H., Peng, J., Jian, W., Zhang, H., Dong, J., Mills, G. B., Hung, M.-C., & Meric-Bernstam, F. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0043 · Cited by 285
Song, X., Zhao, Y., Wu, W., Bi, Y., Cai, Z., Chen, Q., Li, Y., & Hou, S. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.08.034 · Cited by 282
Preparation and characterization of sterile and freeze-dried sub-200 nm nanoparticles
Konan, Y. N., Gurny, R., & Allémann, E. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00944-9 · Cited by 279
Davis, F. F. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00021-2 · Cited by 278
Chemical degradation of peptides and proteins in PLGA: A review of reactions and mechanisms
Houchin, M. L., & Topp, E. M. (2008) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21176 · Cited by 277
Vasir, J. K., & Labhasetwar, V. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.07.020 · Cited by 268
PLGA-based drug delivery systems: Importance of the type of drug and device geometry
Klose, D., Siepmann, F., Elkharraz, K., & Siepmann, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.10.030 · Cited by 267
Park, E. K., Lee, S. B., & Lee, Y. M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.04.008 · Cited by 264
Encapsulation of dexamethasone into biodegradable polymeric nanoparticles
GOMEZGAETE, C., TSAPIS, N., BESNARD, M., BOCHOT, A., & FATTAL, E. (2007) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.11.028 · Cited by 259
Poly (glycolic acid-co-dl-lactic acid): diffusion or degradation controlled drug delivery?
Shah, S. S., Cha, Y., & Pitt, C. G. (1992) · Journal of Controlled Release · doi:10.1016/0168-3659(92)90171-m · Cited by 250
Betancourt, T., Brown, B., & Brannon-Peppas, L. (2007) · Nanomedicine · doi:10.2217/17435889.2.2.219 · Cited by 249
Kalaria, D. R., Sharma, G., Beniwal, V., & Ravi Kumar, M. N. V. (2009) · Pharmaceutical Research · doi:10.1007/s11095-008-9763-4 · Cited by 246
Kim, H. K., Chung, H. J., & Park, T. G. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.02.004 · Cited by 246
Shenoy, D., Little, S., Langer, R., & Amiji, M. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-8343-0 · Cited by 246
Kim, S. H., Jeong, J. H., Chun, K. W., & Park, T. G. (2005) · Langmuir · doi:10.1021/la0502084 · Cited by 242
Improving Penetration in Tumors With Nanoassemblies of Phospholipids and Doxorubicin
Tang, N., Du, G., Wang, N., Liu, C., Hang, H., & Liang, W. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm027 · Cited by 239
Pastorino, F., Brignole, C., Di Paolo, D., Nico, B., Pezzolo, A., Marimpietri, D., Pagnan, G., Piccardi, F., Cilli, M., Longhi, R., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2117 · Cited by 232
Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis
Patil, S. D., Papadmitrakopoulos, F., & Burgess, D. J. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.10.013 · Cited by 230
Alyautdin, R. N., Tezikov, E. B., Ramge, P., Kharkevich, D. A., Begley, D. J., & Kreuter, J. (1998) · Journal of Microencapsulation · doi:10.3109/02652049809006836 · Cited by 229
Drug targeting to the colon with lectins and neoglycoconjugates
Minko, T. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.017 · Cited by 222
Intracellular trafficking of nuclear localization signal conjugated nanoparticles for cancer therapy
Misra, R., & Sahoo, S. K. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.11.010 · Cited by 219
The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres
Johnson, O. L., Jaworowicz, W., Cleland, J. L., Bailey, L., Charnis, M., Duenas, E., Wu, C., Shepard, D., Magil, S., Last, T., et al. (1997) · Pharmaceutical Research · doi:10.1023/a:1012142204132 · Cited by 217
The direct activation of human multidrug resistance gene (MDR1) by anticancer agents
Kohno, K., Sato, S.-I., Takano, H., Matsuo, K.-I., & Kuwano, M. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92761-7 · Cited by 216
Simamora, P., Alvarez, J. M., & Yalkowsky, S. H. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00617-7 · Cited by 211
Song, X. R., Cai, Z., Zheng, Y., He, G., Cui, F. Y., Gong, D. Q., Hou, S. X., Xiong, S. J., Lei, X. J., & Wei, Y. Q. (2009) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2009.02.018 · Cited by 211
Scholes, P. D., Coombes, A. G. A., Illum, L., Daviz, S. S., Vert, M., & Davies, M. C. (1993) · Journal of Controlled Release · doi:10.1016/0168-3659(93)90103-c · Cited by 208
Schliecker, G., Schmidt, C., Fuchs, S., & Kissel, T. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00243-6 · Cited by 208
Nanoparticles of biodegradable polymers for new-concept chemotherapy
Feng, S.-S. (2004) · Expert Review of Medical Devices · doi:10.1586/17434440.1.1.115 · Cited by 206
Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells
Tahara, K., Sakai, T., Yamamoto, H., Takeuchi, H., Hirashima, N., & Kawashima, Y. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.07.023 · Cited by 206
Folate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA–PEG–folate conjugate
Esmaeili, F., Ghahremani, M. H., Ostad, S. N., Atyabi, F., Seyedabadi, M., Malekshahi, M. R., Amini, M., & Dinarvand, R. (2008) · Journal of Drug Targeting · doi:10.1080/10611860802088630 · Cited by 203
Molecular imaging and therapy of atherosclerosis with targeted nanoparticles
Wickline, S. A., Neubauer, A. M., Winter, P. M., Caruthers, S. D., & Lanza, G. M. (2007) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.20866 · Cited by 201
Nanoparticulate systems for the delivery of antisense oligonucleotides
Lambert, G., Fattal, E., & Couvreur, P. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00116-2 · Cited by 201
Derakhshandeh, K., Erfan, M., & Dadashzadeh, S. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.09.004 · Cited by 200
Kreuter, J., Petrov, V. E., Kharkevich, D. A., & Alyautdin, R. N. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00061-8 · Cited by 196
Choi, S.-W., & Kim, J.-H. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.06.003 · Cited by 196
Teixeira, M., Alonso, M. J., Pinto, M. M. M., & Barbosa, C. M. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.09.002 · Cited by 188
Gelperina, S. E., Khalansky, A. S., Skidan, I. N., Smirnova, Z. S., Bobruskin, A. I., Severin, S. E., Turowski, B., Zanella, F. E., & Kreuter, J. (2002) · Toxicology Letters · doi:10.1016/s0378-4274(01)00456-8 · Cited by 185
Song, K. C., Lee, H. S., Choung, I. Y., Cho, K. I., Ahn, Y., & Choi, E. J. (2006) · Colloids and Surfaces A: Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2005.10.064 · Cited by 183
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer
Zeisser-Labouèbe, M., Lange, N., Gurny, R., & Delie, F. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.07.012 · Cited by 180
Stability and freeze-drying of cyclosporine loaded poly(d,l lactide–glycolide) carriers
Chacón, M., Molpeceres, J., Berges, L., Guzmán, M., & Aberturas, M. R. (1999) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(98)00066-9 · Cited by 178
Manuela Gaspar, M., Blanco, D., Cruz, M. E. M., & José Alonso, M. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00196-x · Cited by 175
Patel, N. R., Rathi, A., Mongayt, D., & Torchilin, V. P. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.082 · Cited by 173
Selective targeting of cancer cells using synthetic peptides
Shadidi, M., & Sioud, M. (2003) · Drug Resistance Updates · doi:10.1016/j.drup.2003.11.002 · Cited by 170
Zinc(II) phthalocyanine loaded PLGA nanoparticles for photodynamic therapy use
Ricci‐Júnior, E., & Marchetti, J. M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.048 · Cited by 169
Nanoparticle drug delivery system for restenosis
Labhasetwar, V., Song, C., & Levy, R. J. (1997) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(96)00483-8 · Cited by 169
Thioune, O., Fessi, H., Devissaguet, J. P., & Puisieux, F. (1997) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(96)04830-2 · Cited by 161
Esmaeili, F., Ghahremani, M. H., Esmaeili, B., Khoshayand, M. R., Atyabi, F., & Dinarvand, R. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.07.038 · Cited by 159
VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo
Gosk, S., Moos, T., Gottstein, C., & Bendas, G. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.12.021 · Cited by 158
Applications of Nanotechnology to Atherosclerosis, Thrombosis, and Vascular Biology
Wickline, S. A., Neubauer, A. M., Winter, P. M., Caruthers, S. D., & Lanza, G. M. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000201069.47550.8b · Cited by 158
Modification of nanostructured materials for biomedical applications
Xu, T., Zhang, N., Nichols, H. L., Shi, D., & Wen, X. (2006) · Materials Science and Engineering C · doi:10.1016/j.msec.2006.05.029 · Cited by 155
Alexis, F., Venkatraman, S. S., Rath, S. K., & Boey, F. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.011 · Cited by 155
Esmaeili, F., Hosseini-Nasr, M., Rad‐Malekshahi, M., Samadi, N., Atyabi, F., & Dinarvand, R. (2007) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2007.03.003 · Cited by 150
Stabilizer-free poly(lactide-co-glycolide) nanoparticles for multimodal biomedical probes
Cheng, F., Wang, S. P.-H., Su, C.-H., Tsai, T.-L., Wu, P., Shieh, D.-B., Chen, J., Hsieh, P. C. H., & Yeh, C. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.01.010 · Cited by 148
Alyautdin, R. N., Gothier, D., Петров, Kharkevich, D. A., & Kreuter, J. (1995) · European Journal of Pharmaceutics and Biopharmaceutics · Cited by 148
Zhu, G., & Schwendeman, S. P. (2000) · Pharmaceutical Research · doi:10.1023/a:1007513425337 · Cited by 147
Tissue biocompatibility of kevlar aramid fibers and polymethylmethacrylate, composites in rabbits
Henderson, J. D., Mullarky, R. H., & Ryan, D. E. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820210110 · Cited by 147
Preparation of injectable controlled-release microcapsules by a solvent-evaporation process
Tice, T. R., & Gilley, R. M. (1985) · Journal of Controlled Release · doi:10.1016/0168-3659(85)90056-2 · Cited by 147
Kang, J., & Schwendeman, S. P. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060041n · Cited by 144
Butoescu, N., Seemayer, C. A., Foti, M., Jordan, O., & Doelker, É. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.017 · Cited by 144
MT1-MMP: Universal or particular player in angiogenesis?
Genı́s, L., Gálvez, B. G., Gonzalo, P., & Arroyo, A. G. (2006) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-7891-z · Cited by 141
Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes
Lam, X. M., Duenas, E. T., Daugherty, A. L., Levin, N., & Cleland, J. L. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00224-8 · Cited by 140
Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells
Gryparis, E. C., Hatziapostolou, M., Papadimitriou, Ε., & Avgoustakis, K. (2007) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.12.017 · Cited by 139
Biodegradable Nanoparticles for Direct or Two-Step Tumor Immunotargeting
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050137k · Cited by 139
Prior, S., Gander, B., Blarer, N., Merkle, H. P., Subirá, M. L., Irache, J. M., & Gamazo, C. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(01)00218-4 · Cited by 138
PEGylated polycyanoacrylate nanoparticles as vector for drug delivery in prion diseases
Calvo, P., Gouritin, B., Brigger, I., Lasmézas, C. I., Deslys, J., Williams, A., Andreux, J. P., Dormont, D., & Couvreur, P. (2001) · Journal of Neuroscience Methods · doi:10.1016/s0165-0270(01)00450-2 · Cited by 138
Reddy, L. H., Sharma, R. K., Chuttani, K., Mishra, A. K., & Murthy, R. R. (2004) · The AAPS Journal · doi:10.1208/aapsj060323 · Cited by 135
Influence of the Surfactant Concentration on the Body Distribution of Nanoparticles
Araújo, L. C. D. P., Löbenberg, R., & Kreuter, J. (1999) · Journal of drug targeting · doi:10.3109/10611869908996844 · Cited by 133
Ong, B. Y. S., Ranganath, S. H., Lee, L. Y., Fan, L., Lee, H. S., Sahinidis, N. V., & Wang, C. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.02.030 · Cited by 132
Mo, Y., & Lim, L. Y. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.06.024 · Cited by 128
Injectable Sustained Release Microparticles of Curcumin: A New Concept for Cancer Chemoprevention
Shahani, K., Swaminathan, S. K., Freeman, D. J., Blum, A. P., Ma, L., & Panyam, J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4362 · Cited by 128
Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin™ for active targeting
Bossy-Nobs, L., Buchegger, F., Gurny, R., & Allémann, É. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.04.006 · Cited by 117
Wang, Y. M., Sato, H., Adachi, I., & Horikoshi, I. (1996) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.44.1935 · Cited by 113
Aqueous nanodispersions prepared by a salting-out process
Ibrahim, H., Bindschaedler, C., Doelker, É., Buri, P. A., & Gurny, R. (1992) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(92)90248-z · Cited by 110
Role of nanocarrier systems in cancer nanotherapy
Mozafari, M. R., Pardakhty, A., Azarmi, S., Jazayeri, J. A., Nokhodchi, A., & Omri, A. (2009) · Journal of Liposome Research · doi:10.3109/08982100902913204 · Cited by 107
Synaptic transmission of neural stem cells seeded in 3-dimensional PLGA scaffolds
Xiong, Y., Zeng, Y., Zeng, C., Du, B.-L., He, L., Quan, D., Zhang, W., Jun-mei, W., Wu, J., Li, Y., et al. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.03.046 · Cited by 104
D’Souza, S. S., Faraj, J. A., & DeLuca, P. P. (2005) · AAPS PharmSciTech · doi:10.1208/pt060470 · Cited by 102
Cited by
Nanochemistry and Nanomedicine for Nanoparticle-based Diagnostics and Therapy
Chen, G., Roy, I., Yang, C., & Prasad, P. N. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00148 · Cited by 1,499
Dendrimers: synthesis, applications, and properties
Abbasi, E., Aval, S. F., Akbarzadeh, A., Milani, M., Nasrabadi, H. T., Joo, S. W., Hanifehpour, Y., Nejati-Koshki, K., & Pashaei-Asl, R. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-247 · Cited by 1,279
Self-citationCarbon nanotubes: properties, synthesis, purification, and medical applications
Eatemadi, A., Daraee, H., Karimkhanloo, H., Kouhi, M., Zarghami, N., Akbarzadeh, A., Abasi, M., Hanifehpour, Y., & Joo, S. W. (2014) · Nanoscale Research Letters · doi:10.1186/1556-276x-9-393 · Cited by 1,239
Self-citationInsight into nanoparticle cellular uptake and intracellular targeting
Yameen, B., Choi, W. I., Vilos, C., Swami, A., Shi, J., & Farokhzad, O. C. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.06.038 · Cited by 787
PLGA-Based Nanoparticles in Cancer Treatment
Rezvantalab, S., Drude, N. I., Moraveji, M. K., Güvener, N., Koons, E. K., Shi, Y., Lammers, T., & Kiessling, F. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01260 · Cited by 607
Metadata
- Authors
- Tabatabaei Mirakabad, F. S., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., & Joo, S. W.
- Venue
- Asian Pacific Journal of Cancer Prevention
- Published
- 2014-01-30
- Volume
- 15
- Issue
- 2
- Pages
- 517-535
- ISSN
- 1513-7368 (ISSN-L)
- OpenAlex
- W2077188806
- Cited by
- 542
- References
- 226
- FWCI
- 11.19
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.